As opposed to CD103+CD8+ T cells, our in vivo studies showed a strong decrease in the frequency of CD103+FoxP3+CD4+ Treg in αV-knockout tumours, suggesting that CD103 expression in FoxP3+CD4+ and CD8+ T cells is regulated by distinct mechanisms. The gene discussed is FOXP3; the disease is neoplasm.